Woodward Announces Substantial Increase in Share Repurchase Authorization

(NASDAQ:WWD), FORT COLLINS, Colo., Nov. 20, 2025 (GLOBE NEWSWIRE) — Woodward, Inc. (NASDAQ:WWD) today announced that its Board of Directors has approved a new $1.8 billion, three-year share repurchase authorization, marking a decisive and strategic use of its strong balance sheet to drive shareholder value. Woodward completed its prior $600 million authorization in November 2025, […]

Konica Minolta Healthcare Reinforces Leadership in Advanced Radiography with Seven Scientific Presentations on Dynamic Digital Radiography at RSNA 2025

WAYNE, N.J., Nov. 20, 2025 (GLOBE NEWSWIRE) — Konica Minolta Healthcare Americas, Inc., a leader in medical diagnostic imaging and healthcare information technology, is pleased to announce seven scientific presentations on Dynamic Digital Radiography (DDR) at the upcoming 2025 Annual Meeting of the Radiological Society of North America (RSNA) to be held November 30 –

Aduro Clean Technologies Reports Successful Pilot-Scale Steam-Cracking of Plastic-Derived Hydrochemolytic(TM) Oil

(CNSX:ACT.CN),(OTC US:ACTHF),(Other OTC:ACTHF),(Boerse Frankfurt – Freiverkehr:9D5),(NASDAQ:ADUR), LONDON, Ontario, Nov. 20, 2025 (GLOBE NEWSWIRE) — Aduro Clean Technologies Inc. (“Aduro” or the “Company“) (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5), a clean technology company using the power of chemistry to transform lower value feedstocks, like waste plastics, heavy bitumen, and renewable oils, into resources for the 21st

BellRing Brands Announces New Share Repurchase Authorization of $600 Million

(NYSE:BRBR), ST. LOUIS, Nov. 20, 2025 (GLOBE NEWSWIRE) — BellRing Brands, Inc. (NYSE:BRBR) today announced its Board of Directors approved a $600 million share repurchase authorization over the next two years, with share repurchases under the new authorization beginning on November 19, 2025. As of November 19, 2025, BellRing had repurchased approximately $123 million under

IP Strategy Regains Compliance with Nasdaq Minimum Bid Price Requirement

(NASDAQ:IPST), GIG HARBOR, Wash., Nov. 20, 2025 (GLOBE NEWSWIRE) — IP Strategy (the “Company”) (Nasdaq: IPST), the first company to adopt a treasury reserve policy centered on the $IP token powered by the Story AI-native blockchain network, today announced that it has received written notice from The Nasdaq Stock Market LLC (“Nasdaq”) advising the Company

RentRedi Earns Top 50 Financial Technology Company Nod for Smart Rent Payment Innovations

NEW YORK, Nov. 20, 2025 (GLOBE NEWSWIRE) — RentRedi, the fastest-growing rental management software built for smart real estate investors, has been named to The Financial Technology Report's Top 50 Financial Technology Companies of 2025, earning national recognition for its intelligent rent payment and collection technologies that help independent landlords grow their businesses and build

Aspida Holdings Ltd. Appoints Suzanne Sadlier As Head of Regulatory Affairs

Durham, NC, Nov. 20, 2025 (GLOBE NEWSWIRE) — Aspida Holdings Ltd. (“Aspida”), a life insurance and annuity company, announced today the appointment of Suzanne Sadlier as Head of Regulatory Affairs. In this role, Ms. Sadlier will oversee regulatory engagement across Aspida's U.S., Bermuda, and Cayman platforms. Ms. Sadlier brings more than two decades of leadership

Catheter Precision Announces Successful LockeT Launch in South Africa

(NYSE MKT: VTAK), FORT MILL, S.C., Nov. 20, 2025 (GLOBE NEWSWIRE) — Catheter Precision, Inc. (VTAK – NYSE/American), a US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market, today announces the rapid commercial uptake of its LockeT closure device in South Africa. With the assistance of local distributor,

Opus Genetics to Participate in Upcoming Investment Conferences

(NASDAQ:IRD), RESEARCH TRIANGLE PARK, N.C., Nov. 20, 2025 (GLOBE NEWSWIRE) — Opus Genetics, Inc. (Nasdaq: IRD) (the “Company” or “Opus Genetics”), a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients with inherited retinal diseases (IRDs), announced today that management will participate in the following investor conferences. BTIG 5th Annual

Valitor Announces Upcoming Presentation at the 15th Annual Ophthalmology Innovation Summit (OIS)

BERKELEY, Calif., Nov. 20, 2025 (GLOBE NEWSWIRE) — Valitor, a biotechnology company engineering a new generation of ophthalmic medicines, today announced its chief executive officer, Gregory D. Kunst, will present preclinical data highlighting the potential of VLTR-559, a long-acting anti-VEGF biologic designed to enable twice-yearly dosing for the treatment of wet age-related macular degeneration (AMD),

Scroll to Top